Utilizing large language models and real-world evidence for enhanced biopharma insights: an interview with Lori Klein, Putnam

Written by The Evidence Base

Lori Klein discusses the current applications of LLMs in healthcare

Large language models (LLMs) offer both opportunities and challenges in the medical setting. They have the potential to unlock insights within the healthcare landscape, particularly in real-world evidence (RWE); however, appropriate regulation and human oversight of their use is essential. In this interview, Lori Klein, PharmD, Partner, Medical & Scientific Affairs Practice Lead (Putnam, Boston, US), discusses the current applications of LLMs in healthcare, strategies for optimization, and the potential future landscape of this rapidly evolving field, a topic she recently presented at the World EPA Congress 2024 (March 12–13, 2024, Amsterdam, The Netherlands). Please could you introduce yourself and...

To view this content, please register now for access

It's completely free